Adial Pharmaceuticals, Inc. (ADIL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.61M | -1.32M | -1.83M | -1.75M | -1.59M | -1.45M | -1.69M | -2.15M | -1.63M | -1.22M | -1.39M | -1.89M | -2.3M | -1.75M | -3.4M | -3.53M | -2.5M | -2.37M | -3.53M | -3.2M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -1.7% | 8.89% | -8.22% | 18.57% | 2.51% | -18.92% | -21.79% | -13.39% | 29.26% | 30.17% | 59.14% | 46.4% | 7.93% | 26.22% | 3.56% | -10.33% | 12.19% | 9.22% | -59.82% | -225.15% |
| Net Income | -2.02M | -2M | -1.79M | 0 | -2.23M | -2.07M | -2.19M | -2.46M | -6.48M | -1.9M | -1.35M | -1.51M | -2.24M | -2.87M | -3.11M | -3.24M | -2.91M | -5.83M | -4.32M | -4.44M |
| Depreciation & Amortization | 141 | 142 | 141 | 141 | 141 | 141 | 142 | 141 | 141 | 141 | 141 | 141 | 141 | 15.55K | 15.26K | 141 | 14.71K | 16.39K | 12.28K | 13.97K |
| Stock-Based Compensation | 0 | 0 | 147.33K | 124.1K | 236.73K | 180.2K | 188.26K | 202.38K | 225.99K | 0 | 268.37K | 0 | 459.58K | 734.14K | 557.01K | 0 | 983.61K | 883.56K | 1.19M | 843.29K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 215.87K | 321.43K | 76.92K | -1.86M | 13.09K | 183.82K | 31.02K | 222.47K | 4.65M | 458.84K | 0 | 438.19K | -760.84K | -325.5K | -75K | 362.97K | -146K | 1.4M | 274.52K | 38.39K |
| Working Capital Changes | 193.98K | 350.03K | -264.12K | -13.69K | 393.45K | 252.81K | 278.28K | -114.85K | -30.1K | 222.91K | -311.81K | -822.9K | 242.19K | 691.64K | -791.9K | -660.62K | -441.24K | 1.16M | -687.54K | 341.95K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -81.64K | 98.92K | -114.83K | 138.69K | 267.36K | -43.78K | 1.39K | 139.26K | 74.14K | 37.82K | -27.78K | -305.76K | 86.37K | 117.64K | -343.05K | -144.3K | 129.07K | 110.69K | -292.22K | -159.99K |
| Cash from Investing | 0 | 0 | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 350K | 350K | 800K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.73K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.73K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 350K | 0 | 800K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 315.28K | 2.6M | 524.68K | 5.3M | 50.65K | 0 | 3.61M | 411.09K | 3.82M | 3.38M | 138.67K | 58 | 609.61K | 0 | 0 | 1.86K | 9.12M | 1.25M | 5.5M | 2.81M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 315.28K | 2.6M | 524.68K | 5.3M | 50.65K | 0 | 3.61M | 411.09K | 3.82M | 3.38M | 140.33K | 58 | 609.61K | 0 | 0 | 1.86K | 9.12M | 800K | 5.5M | 2.81M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.66K | 0 | 0 | 0 | 0 | 0 | 0 | 455K | 0 | 0 |
| Net Change in Cash | -1.3M | 1.27M | -1.31M | 3.55M | -1.38M | -1.45M | 1.92M | -1.74M | 2.2M | 2.51M | -902.33K | -1.09M | -1.69M | -1.75M | -3.4M | -3.53M | 6.63M | -1.12M | 1.97M | -428.06K |
| Free Cash Flow | -1.61M | -1.32M | -1.83M | -1.75M | -1.59M | -1.45M | -1.69M | -2.15M | -1.63M | 0 | -1.39M | 0 | -2.3M | -1.75M | -3.4M | -3.53M | -2.5M | -2.37M | -3.53M | -3.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -1.7% | 8.89% | -8.22% | 18.57% | 2.51% | - | -21.79% | - | 29.26% | 100% | 59.14% | 100% | 7.93% | 26.22% | 3.56% | -9.19% | 13.14% | 9.22% | -59.82% | -228.58% |
| FCF per Share | -1.18 | -1.19 | -2.07 | -4.12 | -2.13 | -1.96 | -7.26 | -12.84 | -13.76 | - | -29.51 | - | -54.29 | -41.00 | -82.70 | -90.84 | -67.40 | -71.44 | -111.15 | -115.03 |
| FCF Conversion (FCF/Net Income) | 0.80x | 0.66x | 1.02x | 0.89x | 0.71x | 0.70x | 0.77x | 0.87x | 0.25x | 0.64x | 1.00x | -1.74x | 0.79x | 0.61x | 1.09x | 0.92x | 0.86x | 0.41x | 0.82x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |